Author(s): Shah SS, Tsang SH, Mahajan VB
Abstract Share this page
Abstract BACKGROUND: Recent evidence suggests erythropoietin (EPO) and the erythropoietin receptor (EPOR) may play a direct role in the pathogenesis of diabetic retinopathy. Better characterization of the EPO-EPOR signaling system in the ischemic retina may offer a new therapeutic modality for ischemic ophthalmic diseases. This study was performed to identify EPOR mRNA expression in the human diabetic eye. FINDINGS: EPOR antisense RNA probes were validated on human pancreas tissue. In the normal eye, EPOR was expressed in the retinal ganglion cell layer. Minimal expression was observed in the inner and outer nuclear layer. Under conditions of diabetic retinopathy, EPOR expression shifted to photoreceptor cells. Increased expression was also observed in the peripheral retina. CONCLUSION: EPOR expression may be a biomarker or contribute to disease mechanisms in diabetic retinopathy.
This article was published in BMC Res Notes
and referenced in Journal of Diabetes & Metabolism